{"id":578,"date":"2012-09-01T12:00:00","date_gmt":"2012-09-01T10:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2012\/statine-fuer-alle-ueber-50-jahre"},"modified":"2022-03-17T14:12:27","modified_gmt":"2022-03-17T13:12:27","slug":"statine-fuer-alle-ueber-50-jahre","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2012\/statine-fuer-alle-ueber-50-jahre","title":{"rendered":"Statine f\u00fcr alle \u00fcber 50 Jahre?"},"content":{"rendered":"<p>Zusammenfassung: In einer Metaanalyse der Cholesterol Treatment Trialists wurden die Ergebnisse 27 randomisierter Studien zur Wirkung von Statinen neu ausgewertet. In 22 Studien (134.537 Patienten) war Statin gegen Plazebo getestet worden und in f\u00fcnf Studien (39.612 Patienten) die Wirkung einer h\u00f6heren Dosierung im Vergleich zur Standard-Dosierung. Untersucht wurde die j\u00e4hrliche Rate kardiovaskul\u00e4rer Komplikationen sowie die [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zusammenfassung: In einer Metaanalyse der Cholesterol Treatment Trialists wurden die Ergebnisse 27 randomisierter Studien zur Wirkung von Statinen neu ausgewertet. In 22 Studien (134.537 Patienten) war Statin gegen Plazebo getestet worden und in f\u00fcnf Studien (39.612 Patienten) die Wirkung einer h\u00f6heren Dosierung im Vergleich zur Standard-Dosierung. Untersucht wurde die j\u00e4hrliche Rate kardiovaskul\u00e4rer Komplikationen sowie die [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[684,495,60,1272,1046,1274,451,449,1273,1166,71,68,455,453,85,86,498,456,454,65,83,84,87,801,1275,79,1043,56,505,443],"class_list":["post-578","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-akutes-koronarsyndrom","tag-angina-pectoris","tag-apoplektischer-insult","tag-arteriosklerose","tag-atorvastatin","tag-cholesterin","tag-cholesterinsynthese-hemmer","tag-cse-hemmer","tag-ctt-studie","tag-fluvastatin","tag-herzinfarkt","tag-hirninfarkt","tag-hmg-coa-reduktase-hemmer","tag-hypercholesterinaemie","tag-koronarangiografie","tag-koronarangiographie","tag-koronare-herzkrankheit","tag-lipidsenker","tag-lovastatin","tag-myokardinfarkt","tag-pci","tag-perkutane-koronarintervention","tag-perkutane-transluminale-koronare-angioplastie","tag-pravastatin","tag-procam-tabellen","tag-ptca","tag-rosuvastatin","tag-schlaganfall","tag-simvastatin","tag-statine"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=578"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/578\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=578"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=578"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}